BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. (BMRN) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · BMRN · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
4
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
BioMarin Pharmaceutical Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
BMRN insider buying and selling by quarter
BMRN insider selling · BMRN insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · BMRN ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
BMRN executive sell shares · BMRN board member insider trading · BMRN insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 2, 2026 | Countouriotis Athena Director | Award | 7,490 | — | Form 4 |
| Jun 2, 2026 | Walbert Timothy P Director | Award | 7,490 | — | Form 4 |
| Jun 2, 2026 | Ho Maykin Director | Award | 7,490 | — | Form 4 |
| Jun 2, 2026 | HOMBACH ROBERT J. Director | Award | 7,490 | — | Form 4 |
| Jun 2, 2026 | Enyedy Mark J Director | Award | 7,490 | — | Form 4 |
| Jun 2, 2026 | Dere Willard H Director | Award | 7,490 | — | Form 4 |
| Jun 2, 2026 | CLARK IAN T Director | Award | 7,490 | — | Form 4 |
| Jun 2, 2026 | Bodem Barbara W. Director | Award | 7,490 | — | Form 4 |
| Jun 2, 2026 | ANDERSON ELIZABETH M Director | Award | 7,490 | — | Form 4 |
| May 20, 2026 | Hubbard Cristin EVP, Chief Commercial Officer | Other | 2,318 | $116K | Form 4 |
| May 7, 2026 | Friberg Gregory R EVP, Chief R&D Officer | Sale | 3,281 | $177K | Form 4 |
| Mar 18, 2026 | Davis George Eric EVP, Chief Legal Officer | Other | 1,273 | $71K | Form 4 |
| Mar 17, 2026 | Guyer Charles Greg EVP, Chief Technical Officer | Other | 1,693 | $95K | Form 4 |
| Mar 17, 2026 | Mueller Brian EVP, Chief Financial Officer | Other | 2,117 | $119K | Form 4 |
| Mar 17, 2026 | Hardy Alexander CEO · Director | Other | 4,252 | $238K | Form 4 |
| Mar 16, 2026 | Hubbard Cristin EVP, Chief Commercial Officer | Award | 15,410 | — | Form 4 |
| Mar 17, 2026 | Hubbard Cristin EVP, Chief Commercial Officer | Other | 1,245 | $70K | Form 4 |
| Mar 16, 2026 | Friberg Gregory R EVP, Chief R&D Officer | Award | 19,150 | — | Form 4 |
| Mar 17, 2026 | Friberg Gregory R EVP, Chief R&D Officer | Other | 1,629 | $91K | Form 4 |
| Mar 16, 2026 | Guyer Charles Greg EVP, Chief Technical Officer | Award | 14,990 | — | Form 4 |
| Mar 13, 2026 | Guyer Charles Greg EVP, Chief Technical Officer | Other | 9,109 | $533K | Form 4 |
| Mar 16, 2026 | Davis George Eric EVP, Chief Legal Officer | Award | 14,570 | — | Form 4 |
| Mar 16, 2026 | Davis George Eric EVP, Chief Legal Officer | Other | 7,177 | $420K | Form 4 |
| Mar 16, 2026 | Mueller Brian EVP, Chief Financial Officer | Award | 18,740 | — | Form 4 |
| Mar 13, 2026 | Mueller Brian EVP, Chief Financial Officer | Other | 9,945 | $582K | Form 4 |
Hubbard Cristin
EVP, Chief Commercial Officer
Date
May 20
Shares
2,318
Price
$50.20
Value
$116K
Friberg Gregory R
EVP, Chief R&D Officer
Date
May 7
Shares
3,281
Price
$53.85
Value
$177K
Davis George Eric
EVP, Chief Legal Officer
Date
Mar 18
Shares
1,273
Price
$56.05
Value
$71K
Guyer Charles Greg
EVP, Chief Technical Officer
Date
Mar 17
Shares
1,693
Price
$56.05
Value
$95K
Mueller Brian
EVP, Chief Financial Officer
Date
Mar 17
Shares
2,117
Price
$56.05
Value
$119K
Hubbard Cristin
EVP, Chief Commercial Officer
Date
Mar 16
Shares
15,410
Price
—
Value
—
Hubbard Cristin
EVP, Chief Commercial Officer
Date
Mar 17
Shares
1,245
Price
$56.05
Value
$70K
Friberg Gregory R
EVP, Chief R&D Officer
Date
Mar 16
Shares
19,150
Price
—
Value
—
Friberg Gregory R
EVP, Chief R&D Officer
Date
Mar 17
Shares
1,629
Price
$56.05
Value
$91K
Guyer Charles Greg
EVP, Chief Technical Officer
Date
Mar 16
Shares
14,990
Price
—
Value
—
Guyer Charles Greg
EVP, Chief Technical Officer
Date
Mar 13
Shares
9,109
Price
$58.51
Value
$533K
Davis George Eric
EVP, Chief Legal Officer
Date
Mar 16
Shares
14,570
Price
—
Value
—
Davis George Eric
EVP, Chief Legal Officer
Date
Mar 16
Shares
7,177
Price
$58.51
Value
$420K
Mueller Brian
EVP, Chief Financial Officer
Date
Mar 16
Shares
18,740
Price
—
Value
—
Mueller Brian
EVP, Chief Financial Officer
Date
Mar 13
Shares
9,945
Price
$58.51
Value
$582K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About BMRN insider trading
BMRN insider trades
BioMarin Pharmaceutical Inc. (BMRN) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Davis George Eric (EVP, Chief Legal Officer), Guyer Charles Greg (EVP, Chief Technical Officer), Mueller Brian (EVP, Chief Financial Officer). Over the past 12 months, 5 insiders have filed transactions with the SEC. BMRN insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For BioMarin Pharmaceutical Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
BMRN insider trading · 5 questionsThe insiders of BioMarin Pharmaceutical Inc. (BMRN) include executives and directors such as Davis George Eric (EVP, Chief Legal Officer), Guyer Charles Greg (EVP, Chief Technical Officer), Mueller Brian (EVP, Chief Financial Officer), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026